We are live on ! Find out more
AKTX

Akari Therapeutics
AKTX

7 hedge funds and large institutions have $1.19M invested in Akari Therapeutics in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

31% less capital invested

Capital invested by funds: $1.71M → $1.19M (-$523K)

56% less funds holding

Funds holding: 16 → 7 (-9)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 9

Holders
7
Holders Change
-9
Holders Change %
-56.25%
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
3
Reduced
1
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OFW
Omnia Family Wealth
Florida
+$77.3K
2
Cerity Partners
Cerity Partners
New York
+$28.9K
3
Renaissance Technologies
Renaissance Technologies
New York
+$6.03K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$741K
2
CAM
Cresset Asset Management
Illinois
-$36.8K
3
LPL Financial
LPL Financial
California
-$22.9K
4
Millennium Management
Millennium Management
New York
-$22.8K
5
HP
Hikari Power
Japan
-$22K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$703K -$741K -4,788 -52%
OFW
2
Omnia Family Wealth
Florida
$234K +$77.3K +500 +51%
Cerity Partners
3
Cerity Partners
New York
$93.4K +$28.9K +187 +46%
NMC
4
NEA Management Company
Maryland
$89.3K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$69K +$6.03K +39 +10%
Bank of America
6
Bank of America
North Carolina
$592 – – –
TC
7
Truvestments Capital
Florida
$198 – – –
CPG
8
Cornerstone Planning Group
New Jersey
$20 – – –
CAM
9
Cresset Asset Management
Illinois
– -$36.8K -271 Closed
LPL Financial
10
LPL Financial
California
– -$22.9K -168 Closed
Millennium Management
11
Millennium Management
New York
– -$22.8K -168 Closed
HP
12
Hikari Power
Japan
– -$22K -164 Closed
BMCM
13
Bryn Mawr Capital Management
Pennsylvania
– -$17K -125 Closed
Geode Capital Management
14
Geode Capital Management
Massachusetts
– -$5.14K -38 Closed
UBS Group
15
UBS Group
Switzerland
– -$4.16K -31 Closed
TSS
16
Two Sigma Securities
New York
– -$2.99K -22 Closed
VF
17
Virtu Financial
New York
– -$3K -21 Closed

AKTX Hedge Fund Activity: Q3 2023 in Review

7 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q3 2023, worth a combined $1.19M — down 31% from $1.71M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of AKTX and 0 opened new positions — a net loss of 9 holders — while 1 trimmed existing stakes and 3 added.

The largest buyer was Omnia Family Wealth, adding an estimated $77.3K. The largest seller was Sabby Management, cutting an estimated $741K.

  • 7 institutional investors held Akari Therapeutics (AKTX) as of Q3 2023, down from 16 in Q2 2023.
  • Funds reported $1.19M of Akari Therapeutics stock for Q3 2023, down 31% quarter-over-quarter.
  • 0 funds opened new Akari Therapeutics positions in Q3 2023 and 9 closed out, a net change of -9 holders.
  • The largest Akari Therapeutics buyer in Q3 2023 was Omnia Family Wealth, an estimated $77.3K added.
  • The largest Akari Therapeutics seller in Q3 2023 was Sabby Management, an estimated $741K sold.

Based on aggregated 13F filings for Q3 2023.